Join
Live feed
·
INSIDERFilingvia Quantisnow
Teva Pharmaceutical Industries Limited logo

EVP, Business Development Lippman Evan sold $680,291 worth of Ordinary Shares (18,600 units at $36.57) as part of a pre-agreed trading plan, decreasing direct ownership by 42% to 25,591 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TEVA· Teva Pharmaceutical Industries Limited
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TEVA (Teva Pharmaceutical Industries Limited) and more on Quantisnow.